Page 27 - Sohini Das

Polls may rev up 2-wheeler sales but passenger vehicles likely to be a drag

Trends based on recent state elections and the 2019 general elections: Fada

Anand Mahindra bats for making life simpler for Indian innovators

The PLI schemes are on the right path providing a runway for businesses to foray into new sectors and industries, he said

End of the road for FAME-II scheme for EVs drives up e2W, e3W demand

FAME-II scheme for electric vehicles to end on March 31

Healthcare innovation to double at $60 bn opportunity by FY28 in India

Indian vaccines and biotech market, which was valued at $4 billion in FY23, accounting for 15 percent of the innovation market, has quickly grown from $1.2 billion in FY20

World's first CNG bike launch likely in next quarter, says Rajiv Bajaj

Bajaj Auto, which has more than 30 percent market share in India's three-wheeler market, already has tasted success with CNG technology

Electric two-wheeler sales likely to miss NITI Aayog target for FY24

Dealers feel a major reason for the dip is the reduction of FAME subsidy by the government

Artificial intelligence game changer in tracking cases of tuberculosis

Qure.ai and India Health Fund's qXR tool leading better TB notifications

Tata Motors to split CV, PV businesses into separate listed companies

Demerger move likely to unlock value for EV segment

Private hospitals write to health ministry over rate standardisation

Better insurance cover would enhance price transparency

Advent PE begins merger process of Suven Pharma and Cohance Lifesciences

The merged platform will have mid-30s EBITDA margins, 30 per cent Return on Capital Employed (RoCE) and stable cash flow generation over FY20-23, the statement said

Takeda injects hope: Dengue vaccine clinical trials set to begin in India

Biological E will increase manufacturing capacity to up to 50 million doses a year, accelerating Takeda's plans to manufacture 100 million doses annually within the decade

Several pharma cos step up corrective action plans after crackdown by govt

The orders in the state have now been revoked, with the companies undergoing corrective and preventive action (CAPA) processes

Skoda Auto India to drive in Brezza, Sonet rival in first half of 2025

Plans four EVs for India over next few years

Health care companies check market pulse with IPOs after pandemic

Noticeably, a large number of hospital chains have tapped the public markets. Some of them include Yatharth Hospital, Jupiter Life Line and Global Healthcare

Zydus Lifesciences gets WHO nod for API used in kala-azar treatment

More than 1 billion people live in areas endemic for leishmaniasis or Kala Azar and are at risk of infection

Preventive and wellness tests drive growth for diagnostic companies

Covid-19 led to increase in self-testing awareness, particularly about preventive and wellness services

Indian drug firms look for new opportunities in Saudi Arabia pharma market

Indian drug firms sense opportunity to increase presence in $8.9 bn Saudi market

Zoomcar Q3 results: Revenue slips 19% to $2.4 mn, bottomline improves

The firm said that net revenue declined due to lower number of days booked, resulting in decreased gross billings as Zoomcar prioritised higher-margin bookings in support of its cost reduction efforts

Tractor industry sales likely to dip 5% due to agri activities slowdown

The market leader in tractors in India, Mahindra and Mahindra, felt that the year would end with around 900,000 units in sales compared to 945,000 units sold in 2022-23

Commercial vehicle sales likely to enter into a downcycle in 2024-25

Volumes are expected to dip by 4-7 percent